CNCR vs. GDOC
CNCR (Loncar Cancer Immunotherapy ETF) and GDOC (Goldman Sachs Future Health Care Equity ETF) are both Health & Biotech Equities funds. CNCR is passively managed, while GDOC is actively managed. CNCR charges 0.79%/yr vs 0.75%/yr for GDOC.
Performance
CNCR vs. GDOC - Performance Comparison
Loading charts...
Returns By Period
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GDOC
- 1D
- -1.41%
- 1M
- 1.67%
- YTD
- -8.14%
- 6M
- -10.06%
- 1Y
- 5.05%
- 3Y*
- -0.09%
- 5Y*
- —
- 10Y*
- —
CNCR vs. GDOC - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
GDOC Goldman Sachs Future Health Care Equity ETF | -5.23% |
CNCR vs. GDOC - Sectors Allocation Comparison
Sectors
CNCR
GDOC
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
CNCR
GDOC
Financial Services
CNCR
GDOC
-
Basic Materials
CNCR
-
GDOC
-
Communication Services
CNCR
-
GDOC
-
Consumer Cyclical
CNCR
-
GDOC
-
Consumer Defensive
CNCR
-
GDOC
Energy
CNCR
-
GDOC
-
Industrials
CNCR
-
GDOC
-
Real Estate
CNCR
-
GDOC
-
Technology
CNCR
-
GDOC
-
Utilities
CNCR
-
GDOC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CNCR vs. GDOC — Risk / Return Rank
CNCR
GDOC
CNCR vs. GDOC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Goldman Sachs Future Health Care Equity ETF (GDOC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CNCR | GDOC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 0.32 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.20 | — |
Drawdowns
CNCR vs. GDOC - Drawdown Comparison
The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum GDOC drawdown of -31.01%. Use the drawdown chart below to compare losses from any high point for CNCR and GDOC.
Loading charts...
Drawdown Indicators
| CNCR | GDOC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -31.01% | +31.01% |
Max Drawdown (1Y)Largest decline over 1 year | — | -15.67% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -22.51% | — |
Current DrawdownCurrent decline from peak | 0.00% | -15.87% | +15.87% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -15.90% | +15.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 6.78% | — |
Volatility
CNCR vs. GDOC - Volatility Comparison
Loading charts...
Volatility by Period
| CNCR | GDOC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 4.89% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 11.69% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 15.64% | -15.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 18.79% | -18.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 18.79% | -18.79% |
CNCR vs. GDOC - Expense Ratio Comparison
CNCR has a 0.79% expense ratio, which is higher than GDOC's 0.75% expense ratio.
Dividends
CNCR vs. GDOC - Dividend Comparison
CNCR has not paid dividends to shareholders, while GDOC's dividend yield for the trailing twelve months is around 0.35%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GDOC Goldman Sachs Future Health Care Equity ETF | 0.35% | 0.32% | 0.02% | 0.55% | 0.00% |
Frequently Asked Questions
On fees, GDOC is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
GDOC is cheaper with a 0.75% expense ratio, compared with 0.79% for CNCR.
GDOC has the higher dividend yield at 0.35%, compared with 0.00% for CNCR.
They also come from different issuers: Exchange Traded Concepts and Goldman Sachs. Their fees differ too: 0.79% for CNCR and 0.75% for GDOC.
Find the right allocation for CNCR and GDOC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer